Dr Arthur Pratt
Dr Stefan Siebert
Mike Cole
Dr Deborah Stocken
Amy Cranston
et al. | Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial | 2021 |
|
Dr Stefan Siebert
Dr Arthur Pratt
Dr Deborah Stocken
Dr Miranda Patterson
Amy Cranston
et al. | Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial | 2020 |
|
Dr Marina Danilenko
Elaine Stamp
Dr Deborah Stocken
Monique Zangarini
Amy Cranston
et al. | Targeting tropomyosin receptor kinase in cutaneous CYLD defective tumors (TRAC): A randomised placebo-controlled early phase trial with pegcantratinib | 2018 |
|
Amy Cranston
Dr Deborah Stocken
Elaine Stamp
Professor Ruth Plummer
Professor Sir John Burn
et al. | Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial. | 2017 |
|
Amy Cranston
Professor Anthony De Soyza
| Increased severity of respiratory infections associated with elevated anti-LPS IgG2 which inhibits serum bactericidal killing | 2014 |
|
